JENNIFER CURTIS: Open Payments
NPI 1700015989 · KETTERING, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$500 in 23 payments from 16 companies in 2025. Trend: 2023 $193 · 2024 $140 · 2025 $500
Food & beverage: $500
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $98 |
| PFIZER INC. | 2 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| TerSera Therapeutics LLC | 1 | $40 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Tempus AI, Inc | 1 | $30 |
| Pharmacosmos Therapeutics Inc. | 1 | $26 |
| Genentech USA, Inc. | 1 | $25 |
| Aveo Pharmaceuticals, Inc. | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $23 |
Products named: KISQALI, Venclexta, ELREXFIO, Nubeqa, Xermelo, OJJAARA, XT CDX, PLUVICTO.
Industry payments across OH — which companies pay providers there.
